Literature DB >> 26658522

Hormonal Factors and Risk of Psoriasis in Women: A Cohort Study.

Shaowei Wu1, Eunyoung Cho, Wenqing Li, Francine Grodstein, Abrar A Qureshi.   

Abstract

Previous studies suggest that hormonal factors modulate the natural course of psoriasis in women. However, the association of hormonal factors with psoriasis risk has not been assessed using prospective data. We carried out a thorough prospective analysis on the topic in 163,763 women in the Nurses' Health Study I and II. Participants provided information on age at menarche, parity, menopause status, and exogenous hormone use (oral contraceptive and postmenopausal hormone therapy) over the follow-up. We ascertained 1,253 incident psoriasis cases over 2 million person-years. Psoriasis risk appeared to be higher in women with always irregular menstrual cycles in adulthood (multivariate-adjusted hazard ratio=1.32, 95% CI: 1.01-1.73, compared with regular cycles) and surgical menopause (hazard ratio=1.19, 95% CI: 1.01-1.40, compared with natural menopause). Hormone therapy had suggestive but insignificant associations with psoriasis risk. Our results suggest little evidence for hormonal factors and risk of psoriasis in women that need further investigation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26658522     DOI: 10.2340/00015555-2312

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

1.  Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women.

Authors:  Catherine Schairer; Ruth M Pfeiffer; Shahinaz M Gadalla
Journal:  Int J Cancer       Date:  2017-11-24       Impact factor: 7.396

Review 2.  Sex- and gender-related differences in psoriatic arthritis.

Authors:  Sanjana Tarannum; Ying-Ying Leung; Sindhu R Johnson; Jessica Widdifield; Vibeke Strand; Paula Rochon; Lihi Eder
Journal:  Nat Rev Rheumatol       Date:  2022-08-04       Impact factor: 32.286

3.  Transdermal Permeation Assays of Curcumin Aided by CAGE-IL: In Vivo Control of Psoriasis.

Authors:  Rodrigo Boscariol; Érika A Caetano; Denise Grotto; Raquel M Rosa-Castro; José M Oliveira Junior; Marta M D C Vila; Victor M Balcão
Journal:  Pharmaceutics       Date:  2022-04-02       Impact factor: 6.525

Review 4.  The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis.

Authors:  Carole Guillet; Corsin Seeli; Meienberger Nina; Lara Valeska Maul; Julia-Tatjana Maul
Journal:  Int J Womens Dermatol       Date:  2022-04-13

5.  Estrogen Acts Through Estrogen Receptor-β to Promote Mannan-Induced Psoriasis-Like Skin Inflammation.

Authors:  Huimei Wu; Longhui Zeng; Jiaxin Ou; Tingting Wang; Yong Chen; Kutty Selva Nandakumar
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

6.  Aging in psoriasis vulgaris: female patients are epigenetically older than healthy controls.

Authors:  Pavel Borsky; Marcela Chmelarova; Zdenek Fiala; Kvetoslava Hamakova; Vladimir Palicka; Jan Krejsek; Ctirad Andrys; Jan Kremlacek; Vit Rehacek; Martin Beranek; Andrea Malkova; Tereza Svadlakova; Drahomira Holmannova; Lenka Borska
Journal:  Immun Ageing       Date:  2021-03-03       Impact factor: 6.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.